These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3758650)

  • 1. The lymphatic route--III. Pharmacokinetics of human natural interferon-beta injected with albumin as a retarder in rabbits.
    Bocci V; Muscettola M; Naldini A
    Gen Pharmacol; 1986; 17(4):445-8. PubMed ID: 3758650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lymphatic route--II. Pharmacokinetics of human recombinant interferon-alpha 2 injected with albumin as a retarder in rabbits.
    Bocci V; Muscettola M; Naldini A; Bianchi E; Segre G
    Gen Pharmacol; 1986; 17(1):93-6. PubMed ID: 3949153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lymphatic route. IX. Distribution of recombinant interferon-alpha 2 administered subcutaneously with oedematogenic drugs.
    Pessina GP; Bocci V; Carraro F; Naldini A; Paulesu L
    Physiol Res; 1993; 42(4):243-50. PubMed ID: 8280722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lymphatic route. V. Distribution of human natural interferon-beta in rabbit plasma and lymph.
    Bocci V; Pessina GP; Paulesu L; Muscettola M; Valeri A
    J Interferon Res; 1988 Oct; 8(5):633-40. PubMed ID: 3235848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of human recombinant interferon-beta in monkeys and rabbits.
    Gomi K; Morimoto M; Inoue A; Kobayashi H; Deguchi T; Hara T; Nakamizo N
    Gan; 1984 Mar; 75(3):292-300. PubMed ID: 6724230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lymphatic route. 1) Albumin and hyaluronidase modify the normal distribution of interferon in lymph and plasma.
    Bocci V; Muscettola M; Grasso G; Magyar Z; Naldini A; Szabo G
    Experientia; 1986 Apr; 42(4):432-3. PubMed ID: 3956696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lymphatic route. VI. Distribution of recombinant interferon-alpha 2 in rabbit and pig plasma and lymph.
    Bocci V; Pessina GP; Paulesu L; Nicoletti C
    J Biol Response Mod; 1988 Aug; 7(4):390-400. PubMed ID: 3171601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of human lymphoblastoid interferon in rabbits.
    Bocci V; Pessina GP; Pacini A; Paulesu L; Muscettola M; Naldini A; Lunghetti G
    Gen Pharmacol; 1985; 16(3):277-9. PubMed ID: 4018543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human beta-interferon incubated with muscle homogenate is protected by albumin but not by proteinase inhibitors.
    Paulesu L; Pessina GP; Bocci V
    Proc Soc Exp Biol Med; 1992 Jul; 200(3):414-7. PubMed ID: 1615016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different pharmacokinetics between natural and recombinant human interferon beta in rabbits.
    Satoh YI; Kasama K; Kajita A; Shimizu H; Ida N
    J Interferon Res; 1984; 4(3):411-22. PubMed ID: 6491398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of human interferons].
    Furue H; Kobayashi H; Komuro T; Kako M; Mugitani H; Fuse K; Kaise R; Nagai K; Takahashi T; Hirota F
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):935-42. PubMed ID: 6721508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of disappearance from blood and lymphatic delivery of human fibroblast interferon in rat by different administration routes.
    Yoshikawa H; Satoh Y; Naruse N; Takada K; Muranishi S
    J Pharmacobiodyn; 1985 Mar; 8(3):206-10. PubMed ID: 4009412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys.
    Osborn BL; Olsen HS; Nardelli B; Murray JH; Zhou JX; Garcia A; Moody G; Zaritskaya LS; Sung C
    J Pharmacol Exp Ther; 2002 Nov; 303(2):540-8. PubMed ID: 12388634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic absorption is the primary contributor to the systemic availability of epoetin Alfa following subcutaneous administration to sheep.
    McLennan DN; Porter CJ; Edwards GA; Martin SW; Heatherington AC; Charman SA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):345-51. PubMed ID: 15579493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lymphatic route. VIII. Distribution and plasma clearance of recombinant human interleukin-2 after SC administration with albumin in patients.
    Bocci V; Carraro F; Zeuli M; Naldini A; Calabresi F
    Biotherapy; 1993; 6(1):73-7. PubMed ID: 8507546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug elimination kinetics following subconjunctival injection using dynamic contrast-enhanced magnetic resonance imaging.
    Kim SH; Csaky KG; Wang NS; Lutz RJ
    Pharm Res; 2008 Mar; 25(3):512-20. PubMed ID: 17674155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lymphatic route. VII. Distribution of recombinant human interleukin-2 in rabbit plasma and lymph.
    Bocci V; Pessina GP; Nicoletti C; Paulesu L
    J Biol Regul Homeost Agents; 1990; 4(1):25-9. PubMed ID: 2399833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels following intranasal and intravenous administration of human interferon-beta to rabbits.
    Maitani Y; Igawa T; Machida Y; Nagai T
    Drug Des Deliv; 1989 Mar; 4(2):109-19. PubMed ID: 2765103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nephrectomy on the pharmacokinetics of various cloned human interferons in the rat.
    Tokazewski-Chen SA; Marafino BJ; Stebbing N
    J Pharmacol Exp Ther; 1983 Oct; 227(1):9-15. PubMed ID: 6620174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence of two subcutaneous pharmaceutical products of interferon beta la.
    Di Girolamo G; Kauffman MA; González E; Papouchado M; Ramírez A; Keller G; Carbonetto C; Dabsys S; Vidal A; Sterin-Prync A; Diez RA
    Arzneimittelforschung; 2008; 58(4):193-8. PubMed ID: 18540482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.